Blood test for antibodies to the corona virus COVID-19
Antibody testing in private
Background on coronary heart disease
Corona virus is a known deadly virus from the corona family that created a mutation and led to a global epidemic that claimed the lives of thousands around the world.
On February 11, 2020, the World Health Organization gave an official name to the virus: SARS-CoV-2, and to the disease it causes: COVID-19. A month later it was declared a pandemic.
The virus can be transmitted in droplets (airways) from person to person and it manages to survive on various surfaces such as metal and plastic cardboard, ie the infection can also be transmitted by contact. The level of infection is similar to the infection of the flu.
A person who has contracted a virus secretes and can infect the environment at the same time he can also infect during the incubation period (has not yet shown symptoms) or even during the recovery period.
The symptoms of the virus are flu-like symptoms. The vast majority about 88% will develop a fever, about 67% will develop a dry cough, about 38% will suffer from fatigue, about 33% will have phlegm discharge, about 14% will have joint pain and about 13% will have a sore throat or headache.
In advanced stages of the disease, the virus damages the lung tissue and causes visual infiltrates to the point of respiration. These patients may develop respiratory failure and ARDS (acute respiratory distress syndrome). The ratio is 1: 6. Mortality rates range from 2-4%.
IgM antibody usually begins to rise within a week after the initial infection.
IgG antibody appears about 14 days after infection reflecting previous exposure to the virus and the presence of antibodies against the virus.
There is currently no vaccine for the corona virus.
According to the World Health Organization, there is currently no evidence that people who recovered from COVID-19 and developed antibodies
Protected from reinfection or relapse. In addition, even if there is protection following development
Antibodies, the duration of protection is unknown. However, the currently accepted professional assumption in the world is that similar to the known
From other viral diseases, the presence of antibodies is a protection against re-infection.
The issue of corona virus and antibodies among those exposed to the virus has been found in a worldwide study.
We are testing antibodies to corona.
